Am J Clin Oncol

1. AKIN EA, Wallner PE, Alexander S, Barry P, et al
   ACR-ACNM-ARS-SNMMI Practice Parameter for the Performance of Therapy With Radium-223 Dichloride.
   Am J Clin Oncol. 2026;49:127-135.
   

   >> Share

   
   

   
   Anticancer Res

2. SPRAVE T, Fauser S, Paplomatas P, Schafer H, et al
   A Real-World Evaluation of Health-Related Quality of Life Using the EQ-5D-5L Instrument in Patients Undergoing Radiotherapy for Prostate Cancer.
   Anticancer Res. 2026;46:1707-1718.
   

   >> Share

   
   

   
   BJU Int

3. KANEKO M, Yang J, Magoulianitis V, Cacciamani GE, et al
   A transparent, lightweight and sustainable Green Learning AI model for prostate cancer detection on MRI.
   BJU Int. 2026 Feb 26. doi: 10.1111/bju.70203.
   

   >> Share

   
   
4. MALPANI A, Ryan JT, Yu H, Soodana-Prakash N, et al
   Prediction Analysis of Microarray of 50 genes (PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami Active Surveillance Trial (MAST).
   BJU Int. 2026 Feb 27. doi: 10.1111/bju.70202.
   

   >> Share

   
   
5. SHARMA A, Campbell T, Kanabar S, Soanes H, et al
   The PRAGMATIC pathway - PRostate cancer diAGnosis and MAnagement Triage In Clinical care.
   BJU Int. 2026 Feb 26. doi: 10.1111/bju.70191.
   

   >> Share

   
   
6. RUSBRIDGE J, Caglic I, Thavaraja L, Sushentsev N, et al
   The influence of age and the presence of prostate cancer on prostate volume, PSA and PSA density.
   BJU Int. 2026 Feb 23. doi: 10.1111/bju.70169.
   

   >> Share

   
   

   
   BMC Cancer

7. WANG J, Chen X, Yang G, Wang X, et al
   Identification of glycolysis -correlative features for predicting prognosis and investigating immune landscape in prostate cancer.
   BMC Cancer. 2026 Feb 23. doi: 10.1186/s12885-026-15723.
   

   >> Share

   
   
8. WANG X, Xu X, Fang S, Shi X, et al
   Inhibition of nuclear import suppresses androgen receptor action and overcomes resistance in prostate cancer.
   BMC Cancer. 2026 Feb 25. doi: 10.1186/s12885-026-15792.
   

   >> Share

   
   
9. WANG C, Zhang YY, Wang HQ, Huang C, et al
   AHSP as a novel non-invasive urinary biomarker for prostate cancer.
   BMC Cancer. 2026 Feb 27. doi: 10.1186/s12885-026-15796.
   

   >> Share

   
   

   
   Cancer Imaging

10. POROES F, Nobile A, Widmer L, Vidal J, et al
    Maximal radial distance for predicting extraprostatic extension of prostate cancer: a histopathological-radiological study.
    Cancer Imaging. 2026 Feb 21. doi: 10.1186/s40644-026-01011.
    

    >> Share

    
    

    
    Clin Cancer Res

11. JANI CT, Tran E, Zhang N, Tsai J, et al
    Characterizing Longitudinal Molecular Changes in ctDNA in Patients with Metastatic Castration-resistant Prostate Cancer.
    Clin Cancer Res. 2026 Feb 26. doi: 10.1158/1078-0432.CCR-25-3071.
    

    >> Share

    
    

    
    Endocrinology

12. SHARIFI N
    Androgen Metabolism in Prostate Cancer: Recent Advances.
    Endocrinology. 2026 Feb 24:bqag021. doi: 10.1210.
    

    >> Share

    
    
13. READ GH, Pacheco JV, Baumann B, Richards ZA, et al
    Dysregulation of estrogen signaling and HSD17B7 in the prostate stroma of African American men.
    Endocrinology. 2026;167:bqag017.
    

    >> Share

    
    

    
    Eur Urol

14. HERRMANN K, Walz J, MacLennan S, Briganti A, et al
    SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis.
    Eur Urol. 2026;89:260-274.
    

    >> Share

    
    
15. MAYOR N, Light A, Silvanto A, Haider A, et al
    IP8-FLUORESCE: A Prospective Paired Cohort Study Evaluating the Diagnostic Accuracy of Fluorescence Confocal Microscopy for Real-time Assessment of Surgical Margins in Radical Prostatectomy.
    Eur Urol. 2026;89:223-232.
    

    >> Share

    
    
16. PORPIGLIA F, Checcucci E, Volpi G, Stura I, et al
    Artificial Intelligence 3D Augmented Reality-guided Robotic Prostatectomy Versus Cognitive MRI Intervention: Results of the Prospective Randomized RIDERS Trial.
    Eur Urol. 2026;89:233-243.
    

    >> Share

    
    
17. BRATT O, Egevad L
    Re: Active Monitoring, Surgery, and Radiotherapy for Cribriform-positive and Cribriform-negative Prostate Cancer: A Secondary Analysis of the PROTECT Randomized Clinical Trial.
    Eur Urol. 2026 Feb 23:S0302-2838(26)01992-5. doi: 10.1016/j.eururo.2026.
    

    >> Share

    
    

    
    Int J Cancer

18. YANG Z, van Duuren LA, Roobol MJ, Erler NS, et al
    Comparing the effectiveness of prostate cancer screening protocols: European Association of Urology- and European Randomized Study of Screening for Prostate Cancer-based strategies.
    Int J Cancer. 2026 Feb 25. doi: 10.1002/ijc.70406.
    

    >> Share

    
    

    
    Int J Urol

19. KOYAMA Y, Morizane S, Moriyasu E, Hoshino T, et al
    Effect of Neoadjuvant Chemo-Hormonal Therapy on Reducing Recurrence in Patients With Very High-Risk Prostate Cancer Undergoing Robot-Assisted Radical Prostatectomy.
    Int J Urol. 2026;33:e70387.
    

    >> Share

    
    
20. IIDA K, Hayashi Y, Narita K, Itami Y, et al
    Clinical Outcomes of Hypofractionated Radiotherapy With 12 Fraction for Low- and Intermediate-Risk Localized Prostate Cancer.
    Int J Urol. 2026;33:e70391.
    

    >> Share

    
    

    
    J Clin Oncol

21. ARMSTRONG AJ, Morris MJ, Abida W, Aggarwal RR, et al
    Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.
    J Clin Oncol. 2026 Feb 26:JCO2502834. doi: 10.1200/JCO-25-02834.
    

    >> Share

    
    

    
    J Nucl Med

22. BIO IDRISSOU M, Aguiar Ferreira C, Comas Rojas H, Lambert Lepesevich LH, et al
    Preclinical Evaluation of [(177)Lu]Lu-ART-101 for Radiopharmaceutical Therapy of Advanced Prostate Cancer.
    J Nucl Med. 2026 Feb 26:jnumed.125.271543. doi: 10.2967/jnumed.125.271543.
    

    >> Share

    
    
23. KIANI I, Siri MA, Babaei M, Aliasghari MM, et al
    Quantitative PSMA PET Biomarkers for Predicting Response to (177)Lu-PSMA Therapy in Prostate Cancer: A Systematic Review and Meta-analysis.
    J Nucl Med. 2026 Feb 26:jnumed.125.270872. doi: 10.2967/jnumed.125.270872.
    

    >> Share

    
    
24. CHAUSSE G, Hou X, Uribe C, Harsini S, et al
    First-in-Human Evaluation of [(68)Ga]Ga-HTK03149, a PSMA-Targeted Tracer for PET Imaging in Prostate Cancer.
    J Nucl Med. 2026 Feb 26:jnumed.123.266357. doi: 10.2967/jnumed.123.266357.
    

    >> Share

    
    

    
    J Urol

25. LIN DW, Carlsson S, Filson CP, Kim SK, et al
    Updates to Early Detection of Prostate Cancer: AUA/SUO Guideline (2026).
    J Urol. 2026 Feb 25:101097JU0000000000004995. doi: 10.1097/JU.0000000000004995.
    

    >> Share

    
    

    
    Mol Ther Oncol

26. BAKOS G, Bauder-Wust U, Landry J, Roscher M, et al
    EpCAM-PSMA: Potential predictors of treatment outcomes for PSMA-targeted alpha therapies in metastatic castration-resistant prostate cancer.
    Mol Ther Oncol. 2026;34:201143.
    

    >> Share

    
    

    
    PLoS One

27. XIANG AP, Yuan XF, Qin ZQ
    Survival study of cytoreductive prostatectomy for prostate cancer with lung metastasis: A propensity score matching study based on the SEER database.
    PLoS One. 2026;21:e0342758.
    

    >> Share

    
    

    
    Prostate

28. LIANG Y, Chen Z, Zhang J, Liao Z, et al
    A Dual-Threshold Strategy Enables Reliable Biopsy-Free Diagnosis of High-Risk Prostate Cancer.
    Prostate. 2026 Feb 23. doi: 10.1002/pros.70145.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share